| 发明名称 |
Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies |
| 摘要 |
<p>Discloses use of a cell comprising a chimeric antigen receptor in the manufacture of a medicament for the treatment of a solid tumour cancer cell in an individual, wherein the chimeric antigen receptor recognises the CD70 antigen and comprises an intracellular signalling domain.</p> |
| 申请公布号 |
NZ609967(A) |
申请公布日期 |
2015.04.24 |
| 申请号 |
NZ20110609967 |
申请日期 |
2011.10.27 |
| 申请人 |
BAYLOR COLLEGE OF MEDICINE |
发明人 |
GOTTSCHALK STEPHEN M. G;SHAFFER DONALD R.;SPENCER DAVID M. |
| 分类号 |
A61K39/00 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
